Will be interesting. What is the date for the FDA meeting. Have been travelling with little internet access. The other thing will be the next short number. We are holding over $8 which makes the shorts position ever more expensive as you know if you would try to borrow any shares. With the test results and no need for safety tests approval is likely. Was AMPE telling us something with the production contract? Personally what will be most telling to me is how the marketing is going to go. AMPE needs a marketing agent or partner to make it really happen.